ÂÜÀòÂÒÂ×

Abdullah Jamali has a diverse work experience spanning multiple industries. Abdullah has worked as a Scientist at CytomX Therapeutics, where they played a key role in the early-stage development of antibody, probody, antibody drug conjugates, and probody drug conjugates. Abdullah'sresponsibilities included managing projects, conducting analytical and formulation development, and collaborating with CMO/CRO's. Abdullah also worked as an Associate Scientist at the same company.

Prior to CytomX Therapeutics, Abdullah served as a Formulation Development/Analytical Chemist at Aridis Pharmaceutical. In this role, they focused on drug product formulation development, experimental design and study, and method development.

Abdullah's experience also includes working as a Quality Control Inspector II at Penumbra, Inc., where they conducted inspections of finished products and performed various tests related to product integrity and quality. Abdullah has also held positions as a Research Associate at SDSU Research Foundation, a Teaching Assistant at San Diego State University, a Research Assistant at the Salk Institute for Biological Studies, a Chemist at Inova Diagnostics Inc, and a Process Development Engineer at Verenium Biofuels.

Throughout their career, Abdullah has developed expertise in various techniques and processes, including SEC-HPLC, Lyophilization, CE-SDS, icIEF, ELISA, Karl Fisher, formulation development and screening, in-use compatibility studies, stability studies, and process engineering.

Abdullah Jamali began their education in 2003 at UC San Diego, where they pursued a Bachelor's degree in Biochemistry and Molecular Biology. Abdullah completed their undergraduate studies in 2008. Following that, in 2011, Jamali attended San Diego State University, where they pursued and obtained a Master's degree in Molecular Biology, which they completed in 2014. Abdullah'seducational journey continued in 2022 when they enrolled at Saint Mary's College of California to pursue a Master of Business Administration (MBA) degree with a focus on Entrepreneurship/Entrepreneurial Studies. Abdullah is expected to complete their MBA program in 2024.